Close

Mr Patrick Bidulka

Research Fellow

United Kingdom

My research explores how we can use routinely collected health data to investigate comparative treatment effects where we lack randomised evidence. I focus on comparing:

(1) alternative antidiabetic treatments among people with type 2 diabetes, and

(2) alternative heart attack treatments among people with kidney disease.

I completed an MSc in epidemiology at the London School of Hygiene & Tropical Medicine, and a BSc in pharmacology and economics at McGill University in Montréal, Canada. Alongside my work, I am a PhD candidate.

Prior to joining the LSHTM, I worked at McGill Global Health Programs and the Population Health Research Institute (PHRI) in Hamilton, Canada. I continue to collaborate with researchers at PHRI.

Affiliations

Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health

Teaching

I am a module organiser for the Analysis of Electronic Health Records module.

In addition, I teach on the following MSc modules and short courses:

- Extended Epidemiology

- Statistical Methods in Epidemiology

- Epidemiology in Practice

- Analysis of Electronic Health Records

- Professional Certificate in Pharmacoepidemiology & Pharmacovigilance

I supervise summer projects related to non-communicable disease management and treatment using electronic health records for the following master's courses:

- MSc Epidemiology

- MSc Medical Statistics

- MSc Health Data Science

I also co-lead and supervise for the Health Data Research (HDR)-UK Black Internship Programme at LSHTM, which aims to reduce the underrepresentation of Black people within the health data science sector.

Research

I am currently involved with the following pharmacoepidemiology and health services projects:

- National Cardiac and Renal Audit Initiative (NACARAI)

- Personalised Medicine for Intensification of Treatment (PERMIT): the case for type 2 diabetes mellitus

- Organised Stroke Care Across Income Levels (OSCAIL)

Using routinely collected health care data, mainly from general practices and hospitals in the UK, my research

- Describes services and treatments for type 2 diabetes, cardiovascular disease, and kidney disease in the UK;

- Identifies disparities in the delivery of these health care services/treatments;

- Compares alternative treatment strategies for type 2 diabetes and cardiovascular disease where clinical equipoise persists.

I work with other epidemiologists, health economists, statisticians, clinicians, and patient representatives to apply advanced methodologies and analyses in this research to reduce the impact of biases in these observational data.

Research Area
Electronic health records
Health inequalities
Health outcomes
Health services research
Pharmacovigilance
Implementation science
Disease and Health Conditions
Diabetes
Kidney disease
Mental health
Non-communicable diseases
Stroke
Cardiovascular diseases
Country
Canada
Denmark
India
Rwanda
South Africa
Uganda
United Kingdom
Region
European Union
North America
Sub-Saharan Africa (all income levels)

Selected Publications

Management and outcomes of myocardial infarction in people with impaired kidney function in England.
Scott, J; BIDULKA, P; Taylor, DM; Udayaraj, U; Caskey, FJ; Birnie, K; Deanfield, J; De Belder, M; Denaxas, S; Weston, C; Adlam, D; NITSCH, D;
2023
BMC nephrology
Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform.
COSTELLO, RE; Tazare, J; Piehlmaier, D; HERRETT, E; Parker, EP K; ZHENG, B; Mansfield, KE; HENDERSON, AD; CARREIRA, H; BIDULKA, P; WONG, AY S; WARREN-GASH, C; Hayes, JF; Quint, JK; MacKenna, B; Mehrkar, A; EGGO, RM; Katikireddi, SV; TOMLINSON, L; LANGAN, SM; Mathur, R; LH&W NCS (or CONVALESCENCE) Collaborative,; OpenSAFELY collaborative,;
2023
EClinicalMedicine
Ethnic and socioeconomic disparities in initiation of second-line antidiabetic treatment for people with type 2 diabetes in England: A cross-sectional study.
BIDULKA, P; Mathur, R; Lugo-Palacios, DG; O'NEILL, S; Basu, A; Silverwood, RJ; Charlton, P; BRIGGS, A; SMEETH, L; Adler, AI; DOUGLAS, IJ; Khunti, K; GRIEVE, R;
2022
Diabetes, obesity & metabolism
Impact of chronic kidney disease on case ascertainment for hospitalised acute myocardial infarction: an English cohort study.
BIDULKA, P; Scott, J; Taylor, DM; Udayaraj, U; Caskey, F; Teece, L; Sweeting, M; Deanfield, J; De Belder, M; Denaxas, S; Weston, C; Adlam, D; NITSCH, D;
2022
BMJ Open
Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study.
BIDULKA, P; O'NEILL, S; Basu, A; Wilkinson, S; Silverwood, RJ; Charlton, P; BRIGGS, A; Adler, AI; Khunti, K; TOMLINSON, LA; SMEETH, L; DOUGLAS, IJ; GRIEVE, R;
2021
BMJ Open
Adverse outcomes after partner bereavement in people with reduced kidney function: Parallel cohort studies in England and Denmark.
BIDULKA, P; Vestergaard, SV; Hlupeni, A; Kjærsgaard, A; WONG, AY S; LANGAN, SM; Schmidt, SA J; Lyon, S; Christiansen, CF; NITSCH, D;
2021
PLoS ONE
Case-ascertainment of acute myocardial infarction hospitalizations in cancer patients: a cohort study using English linked electronic health data.
Coles, B; Teece, L; Weston, C; De Belder, MA; Oliver-Williams, C; Welch, CA; Rutherford, MJ; Lambert, PC; BIDULKA, P; Paley, L; NITSCH, D; Deanfield, J; Peake, MD; Adlam, D; Sweeting, MJ;
2021
European Heart Journal - Quality of Care and Clinical Outcomes
Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study.
MANSFIELD, KE; MATHUR, R; TAZARE, J; HENDERSON, AD; MULICK, AR; CARREIRA, H; Matthews, AA; BIDULKA, P; Gayle, A; FORBES, H; COOK, S; WONG, AY S; STRONGMAN, H; WING, K; WARREN-GASH, C; CADOGAN, SL; SMEETH, L; Hayes, JF; Quint, JK; MCKEE, M; LANGAN, SM;
2021
The Lancet. Digital health
Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care.
BIDULKA, P; Fu, EL; LEYRAT, C; Kalogirou, F; McAllister, KS L; Kingdon, EJ; MANSFIELD, KE; Iwagami, M; SMEETH, L; Clase, CM; BHASKARAN, K; Van Diepen, M; Carrero, J-J; NITSCH, D; TOMLINSON, LA;
2020
BMC Medicine
Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study.
BIDULKA, P; Iwagami, M; MANSFIELD, KE; Kalogirou, F; WONG, AY S; DOUGLAS, IJ; SMEETH, L; Summers, C; TOMLINSON, LA;
2020
Wellcome Open Research
See more information